Insider trades
Karin Eastham, Director of Veracyte VCYT, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 06/18.
Karin Eastham
Director
- Company
- Veracyte VCYT
- First filing
- 23/01/17
- Trades
- 44 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$1.5M
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
VCYT | Open-market sale10b5-1 plan | 06/18 | 06/22 | 3,729 sh2 trades | $52.89avg. | $197,223.95 | −19.8% |
VCYT | Open-market sale10b5-1 plan | 25/12/05 | 25/12/08 | 20,000 sh3 trades | $45.45avg. | $908,962.56 | −59.6% |
VeracyteVCYT | Open-market sale10b5-1 plan | 25/11/05 | 25/11/07 | 9,674 sh | $40.02 | $387,153.48 | −41.6% |
VeracyteVCYT | Open-market sale10b5-1 plan | 25/06/13 | 25/06/17 | 4,590 sh | $26.66 | $122,369.4 | −24.8% |
VCYT | Open-market sale10b5-1 plan | 25/01/02 | 25/01/06 | 10,000 sh2 trades | $40.30avg. | $402,982.58 | −35.1% |
VCYT | Open-market sale10b5-1 plan | 24/11/19 | 24/11/21 | 14,731 sh3 trades | $38.34avg. | $564,813.62 | −44.3% |
VeracyteVCYT | Open-market sale10b5-1 plan | 24/07/16 | 24/07/18 | 7,500 sh | $25.00 | $187,500 | −18.4% |
VeracyteVCYT | Open-market sale10b5-1 plan | 24/06/11 | 24/06/13 | 3,870 sh | $20.59 | $79,683.3 | −11.7% |
VeracyteVCYT | Open-market sale10b5-1 plan | 24/06/07 | 24/06/11 | 2,500 sh | $20.97 | $52,425 | −7.0% |
VeracyteVCYT | Open-market sale | 24/04/01 | 24/04/02 | 10,000 sh | $21.65 | $216,500 | −23.2% |
VeracyteVCYT | Open-market sale | 23/03/16 | 23/03/17 | 18,750 sh | $22.78 | $427,125 | −44.4% |
VeracyteVCYT | Open-market sale | 23/02/28 | 23/03/02 | 10,000 sh | $25.00 | $250,000 | −29.9% |